Drug Type ASO |
Synonyms XNA 16UK, XNA16UK |
Target |
Action modulators |
Mechanism MSTN modulators(Growth/differentiation factor 8 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | China | 01 Apr 2025 | |
Sarcopenia | Preclinical | China | 01 Apr 2025 | |
Metabolic dysfunction-associated steatotic liver disease | Preclinical | China | 01 May 2023 |